Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Aktuelle Urologie|August 22, 2023
[Emergencies in cancer therapy: surgical indications under systemic therapy]Constantin Rieger, David Pfister, Axel Heidenreich
Current Opinion in Urology|January 12, 2023
Cytoreductive radical prostatectomy: who benefits from the surgical approach?Axel Heidenreich, Pia Paffenholz, David Pfister, et al.
Aktuelle Urologie|March 27, 2024
[Is there an indication for local treatment in metastasised hormone-sensitive prostate cancer?]Constantin Rieger, David Pfister, Jonathan Hollmann, et al.
Urologie (Heidelberg, Germany)|October 24, 2024
[Stage-dependent treatment of seminomas]David Pfister, Constantin Rieger, Felix Seelemeyer, et al.
Urologie (Heidelberg, Germany)|November 26, 2024
[Urothelial carcinoma of the upper and lower urinary tract-which risk factors make early detection worthwhile?]Niklas Westhoff, Constantin Rieger, Axel Heidenreich, et al.
BJU International|March 16, 2024
Cost-effectiveness analysis of different treatment modalities in BCG-unresponsive NMIBCConstantin Rieger, Jörg Schlüchtermann, Enno Storz, et al.
Urologic Oncology|April 23, 2024
HIVEC as an alternative option in non-muscle-invasive bladder cancer: Experiences from a high-volume centerLucas Kastner, Constantin Rieger, David Pfister, et al.
Deutsches Arzteblatt International|February 18, 2025
New Bladder Preservation Strategies in Urothelial Carcinoma of the BladderAxel Heidenreich, Dirk Böhmer, Christian Bolenz, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 5, 2024
Preservation of the native urethral plate and corpus spongiosum combined with buccal mucosa graft plus Orandi's penile skin flap as an alternative to staged urethroplasty for narrow penile stricturesLeonidas Karapanos, Luisa Halbe, Enno Storz, et al.
Urologie (Heidelberg, Germany)|January 21, 2025
[Next generation sequencing (NGS)-based molecular panel analysis for metastatic prostate cancer: how often can we detect druggable mutations? : NGS for metastatic adenocarcinoma of the prostate]Olivia Steenbock, Pia Paffenholz, Constantin Rieger, et al.
Pageof 3